期刊文献+

六例低血磷性骨软化症诊治分析 被引量:3

下载PDF
导出
摘要 【目的】分析6例低血磷性骨软化症临床特征及诊治方法。【方法】对6例患者的临床资料进行分析,探讨其临床特点以提高对该病的早期诊断。【结果】X性连锁低血磷性骨软化症(XLH)2例,常染色体显性遗传低血磷性骨软化症(ADHR)4例,中性磷制剂治疗依从性好,治疗有效。【结论】低血磷性骨软化症是临床中较为少见病例,临床主要表现为骨痛、肌无力、骨骼畸形、病理性骨折、血磷低而血钙正常,血AKP增高,予以新配方中性磷制剂治疗,能明显提高血磷水平,改善愈后。
出处 《医学临床研究》 CAS 2010年第8期1533-1534,共2页 Journal of Clinical Research
  • 相关文献

参考文献6

  • 1廖二元,赵楚生.低磷性骨质软化症和佝偻病,内分泌学[M].北京:人民卫生出版社,2001:1831.
  • 2伍汉文.佝偻病与骨软化症[J].医学临床研究,2002,19(4):263-267. 被引量:9
  • 3肖新华,张红,盛志峰,刘石平,戴如春,罗湘杭,廖二元.低血磷性骨软化症1例[J].中国组织工程研究与临床康复,2008,12(37):7300-7301. 被引量:3
  • 4White KE, Johnson KB, Carn G, et al . The autosomal dominant hypophosphatemie riekets(ADHR)gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting [J]. J Clin Endocrinol Metab ,2001,86(2) :497-500.
  • 5夏维波,孟迅吾,周学瀛.调磷因子:成纤维细胞生长因子23[J].国外医学(内分泌学分册),2004,24(4):241-243. 被引量:11
  • 6廖二元.低血磷性骨软化症/佝偻病,代谢性骨病学[M].北京:人民卫生出版社,2003:811-812.

二级参考文献31

  • 1金世鑫,高慧,沈志卫,马秀萍,周迎生,赵亮.成人骨软化症56例病因分析[J].中国骨质疏松杂志,1995,1(1):52-54. 被引量:7
  • 2邓小戈,伍汉文,超楚生,廖二元.密钙息促绝经后骨质疏松者钙代谢正平衡的序贯试验[J].中华内分泌代谢杂志,1994,10(3):154-156. 被引量:4
  • 3伍汉文.口服钙剂的合理应用[J].中华内科杂志,1995,34(6):243-243.
  • 4Saito H,Kusano K,Kinosaki M,et al. Human fibroblast growth factor-23mutants suppress Na+ -dependent phosphate co-transport activity and 1 α,25-dihydroxyvitamin D3 production.J Biol Chem, 2003,278:2206-2211.
  • 5Bai XY,Miao D,Goltzman D,et al. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem, 2003,278: 9843-9849.
  • 6Shimada T, Muto T, Urakawa I, et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology, 2002,143:3179-3182.
  • 7Nesbitt T, Coffman TM, Griffitha R,et al. Crosstransplantation of kidneys in normsl and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. J Clin Invest, 1992,89: 1453-1459.
  • 8Shimada T, Urakawa I, Yamazaki Y, et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type Ⅱ a. Biochem Biophys Res Commun,2004,314:409-414.
  • 9Jan de Beur SM, Levine MA. Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab,2002,87:2467-2473.
  • 10Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF-23 as a causative factor of tumor induced osteomalacia. Proc Natl Acad Sci USA,2001,98:6500-6505.

共引文献18

同被引文献13

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部